Page last updated: 2024-11-06

benzimidazole and Chondrosarcoma

benzimidazole has been researched along with Chondrosarcoma in 1 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Chondrosarcoma: A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Chondrosarcoma is the second most common primary bone tumor and it responds poorly to both chemotherapy and radiation treatment."5.38FPipTB, a benzimidazole derivative, induces chondrosarcoma cell apoptosis via endoplasmic reticulum stress and apoptosis signal-regulating kinase 1. ( Chang, CS; Fong, YC; Kuo, SC; Liu, JF; Tang, CH, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, JF1
Chang, CS1
Fong, YC1
Kuo, SC1
Tang, CH1

Other Studies

1 other study available for benzimidazole and Chondrosarcoma

ArticleYear
FPipTB, a benzimidazole derivative, induces chondrosarcoma cell apoptosis via endoplasmic reticulum stress and apoptosis signal-regulating kinase 1.
    Molecular carcinogenesis, 2012, Volume: 51, Issue:4

    Topics: Animals; Apoptosis; Benzimidazoles; Calcium; Cell Death; Cell Line, Tumor; Chelating Agents; Chondro

2012